Introducing Unbiased, Deep HTS by label-free timsTOF Mass Spectrometry (MS) and Surface Plasmon Resonance (SPR)

Introducing for the first time the capability of deep data coverage for HTS and uHTS by the all new timsTOF MALDI PharmaPulse Mass Spectrometer (timsTOF MPP). Bruker is launching at SLAS a new Mass Spectrometry solution combining HTS and uHTS capabilities of MALDI Pharma Pulse with deep data mass spectrometry by high-resolution QTOF and trapped ion mobility separation (TIMS).
Furthermore Bruker is presenting it's Surface Plasmon Resonance (SPR) platform, the SPR Pro Series delivering unprecedented data quality and throughput.
Learn in our workshop how label-free techniques such as mass spectrometry and surface plasmon resonance (SPR) can enhance your high-throughput screening results without compromising on cost or throughput:

Professor Matthias Trost from Newcastle University will share his experience using High-end and High-throughput Mass Spectrometry in his research: MALDI-TOF assay identifies nilotinib as an inhibitor of inflammation in acute myeloid leukaemia.

Bruker specialist Arndt Asperger will introduce the latest high-end mass spectrometer generation now enabled for HTS and even uHTS: timsTOF MALDI PharmaPulse: A next-generation MS based label-free uHTS solution taking advantage of timsTOF technology.

Sven Malik from our Bruker SPR team will focus on our most recent developments to bring SPR up to speed without compromising on data quality: Next level of high throughput SPR screening: 10,000 compound Screen enabled by Bruker SPR.

Philip Compton joining our workshop from IPT (Integrated Protein Technologies, Inc.) to present how IPT’s sample preparation technology can support analytical techniques to improve robustness and data quality even further: A Gateway to Mass Spectrometry: The SampleStream Platform for Biomolecular Purification.